Camber Capital Management

Camber Capital Management as of March 31, 2025

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 31 positions in its portfolio as reported in the March 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 29.8 $839M 1.5M 559.39
Zimmer Holdings (ZBH) 9.0 $255M 2.3M 113.18
Pfizer (PFE) 8.4 $236M 9.3M 25.34
Baxter International (BAX) 7.0 $197M 5.8M 34.23
Humana (HUM) 6.8 $192M 725k 264.60
Spdr Ser Tr S&p Biotech Put Option (XBI) 5.8 $162M 2.0M 81.10
CVS Caremark Corporation (CVS) 5.4 $152M 2.3M 67.75
Globus Med Cl A (GMED) 3.3 $92M 1.3M 73.20
Ptc Therapeutics I (PTCT) 2.7 $76M 1.5M 50.96
Cigna Corp (CI) 2.3 $66M 200k 329.00
Viatris (VTRS) 2.3 $65M 7.5M 8.71
Qiagen Nv Com Shs 2.0 $56M 1.4M 40.15
Ascendis Pharma A/s Sponsored Adr (ASND) 1.9 $55M 350k 155.86
Sarepta Therapeutics (SRPT) 1.8 $51M 800k 63.82
Brookdale Senior Living (BKD) 1.4 $39M 6.3M 6.26
GSK Sponsored Adr Call Option (GSK) 1.4 $39M 1.0M 38.74
BioMarin Pharmaceutical (BMRN) 1.3 $35M 500k 70.69
Concentra Group Holdings Par Common Stock (CON) 1.2 $35M 1.6M 21.70
Evolent Health Cl A (EVH) 1.0 $28M 3.0M 9.47
Ionis Pharmaceuticals (IONS) 0.8 $22M 725k 30.17
Myriad Genetics (MYGN) 0.7 $21M 2.4M 8.87
Zimvie (ZIMV) 0.7 $20M 1.9M 10.80
Moonlake Immunotherapeutics Class A Ord (MLTX) 0.6 $17M 441k 39.07
Denali Therapeutics (DNLI) 0.6 $17M 1.3M 13.60
Anaptysbio Inc Common (ANAB) 0.5 $14M 750k 18.59
Theravance Biopharma (TBPH) 0.3 $8.9M 1.0M 8.93
10x Genomics Cl A Com (TXG) 0.3 $8.7M 1.0M 8.73
Inogen (INGN) 0.2 $7.0M 975k 7.13
Structure Therapeutics Sponsored Ads (GPCR) 0.2 $5.2M 300k 17.31
OraSure Technologies (OSUR) 0.1 $3.0M 900k 3.37
Genmab A/s Sponsored Ads (GMAB) 0.0 $979k 50k 19.58